<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet13313</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-13313</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title></article-title><trans-title-group xml:lang="en"><trans-title>New potential genetic predictors of autoimmune adrenal insufficiency</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Troshina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="en"><p>Ekaterina Troshina, MD, PhD, Professor, Corresponding member </p><p>Moscow</p></bio><email xlink:type="simple">Troshina.Ekaterina@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Nuralieva</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="en"><p>Nurana Nuralieva, MD, PhD</p><p>11, Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">Nuralieva.Nurana@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Yukina</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="en"><p>Marina Yukina, MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">Yukina.Marina@endocrincentr.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Meremyanina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="en"><p>Meremyanina Ekaterina, MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">ekaterina@meremianina.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Dyakov</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="en"><p>Ilya Dyakov, PhD</p><p>Moscow</p></bio><email xlink:type="simple">dyakov.ilya@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Svitich</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="en"><p>Svitich Oksana, MD, PhD, Professor, Academician</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="en" id="aff-1"><institution>Russian Academy of Science</institution><country>Russian Federation</country></aff><aff xml:lang="en" id="aff-2"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff><aff xml:lang="en" id="aff-3"><institution>I. Mechnikov Research Institute for Vaccines and Sera</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>14</day><month>02</month><year>2026</year></pub-date><volume>22</volume><issue>4</issue><fpage>278</fpage><lpage>284</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Troshina E.A., Nuralieva N., Yukina M.Y., Meremyanina E.A., Dyakov I.N., Svitich O.A., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Troshina E.A., Nuralieva N., Yukina M.Y., Meremyanina E.A., Dyakov I.N., Svitich O.A.</copyright-holder><copyright-holder xml:lang="en">Troshina E.A., Nuralieva N., Yukina M.Y., Meremyanina E.A., Dyakov I.N., Svitich O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/13313">https://www.omet-endojournals.ru/jour/article/view/13313</self-uri><trans-abstract xml:lang="en"><p>AIM search for new genetic predictors of autoimmune adrenal insufficiency (AAI).</p><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: In n=54 patients with AAI (isolated and as part of type 2 autoimmune polyglandular syndrome (APS-2; group 1)) and n=32 healthy individuals (group 2) we analyzed polymorphisms in IL28B (rs12979860, rs8099917), TLR9 (rs5743836, rs352140), TLR2 (rs5743708).</p></sec><sec><title>RESULTS</title><p>RESULTS: In group 1, compared with group 2, a predominance of CT genotype of rs12979860 polymorphism of IL28B (p=0.024), and T allele of rs5743836 polymorphism of TLR9 (p=0.044) was revealed. The allele C of rs5743836 polymorphism of TLR9 (p=0.044) was more common in group 2 than in group 1. With respect to other genotypes, alleles and haplotypes, no significant differences (or differences at the level of statistical trend) were found between groups 1 and 2.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: Thus, it is possible that the CT genotype according to the polymorphic locus rs12979860 of the IL28B gene and the allele T of the rs5743836 polymorphism of the TLR9 gene are prognostic markers that increase the likelihood of developing AAI due to violation the peripheral immune tolerance (IT), whereas the allele C of the rs5743836 polymorphism of the TLR9 gene performs a protective role in this disease in the Russian population.</p></sec></trans-abstract><kwd-group xml:lang="en"><kwd>toll-like receptors</kwd><kwd>interferon-lambda receptor</kwd><kwd>Addison’s disease</kwd><kwd>polymorphisms</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by research project 123021300096-3 “New genetic predictors (variants) of tumor and non-tumor endocrine diseases in adults, determined by whole-exome sequencing, including in nuclear families” (2023–2025).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yukina MYu, Nuralieva NF, Troshina EA. Adrenal insufficiency. Moscow: Medical Information Agency, 2020</mixed-citation><mixed-citation xml:lang="en">Yukina MYu, Nuralieva NF, Troshina EA. Adrenal insufficiency. Moscow: Medical Information Agency, 2020</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yukina M, Erofeeva T, Nuralieva N, Andreeva T, Savvateeva E, Dudko N, Troshina E, Rogaev E, Melnichenko G. Novel Gene Mutations Regulating Immune Responses in Autoimmune Polyglandular Syndrome With an Atypical Course. Journal of the Endocrine Society. 2021;5(8):1–9. doi: https://doi.org/10.1210/jendso/bvab077</mixed-citation><mixed-citation xml:lang="en">Yukina M, Erofeeva T, Nuralieva N, Andreeva T, Savvateeva E, Dudko N, Troshina E, Rogaev E, Melnichenko G. Novel Gene Mutations Regulating Immune Responses in Autoimmune Polyglandular Syndrome With an Atypical Course. Journal of the Endocrine Society. 2021;5(8):1–9. doi: https://doi.org/10.1210/jendso/bvab077</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kanczkowski W. Role of toll-like receptors and inflammation in adrenal gland insufficiency / W. Kanczkowski, K. Zacharowski, S.R. Bornstein // Neuroimmunomodulation. 2010; 17(3):180-183</mixed-citation><mixed-citation xml:lang="en">Kanczkowski W. Role of toll-like receptors and inflammation in adrenal gland insufficiency / W. Kanczkowski, K. Zacharowski, S.R. Bornstein // Neuroimmunomodulation. 2010; 17(3):180-183</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hellesen A. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison’s disease / A. Hellesen, K. Edvardsen, L. Breivik [et al.]. Clin Exp Immunol. 2014;176(3):351-362</mixed-citation><mixed-citation xml:lang="en">Hellesen A. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison’s disease / A. Hellesen, K. Edvardsen, L. Breivik [et al.]. Clin Exp Immunol. 2014;176(3):351-362</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">National Library of Medicine [Electronic resource]. Access mode: https://www.ncbi.nlm.nih.gov/gene/282617</mixed-citation><mixed-citation xml:lang="en">National Library of Medicine [Electronic resource]. Access mode: https://www.ncbi.nlm.nih.gov/gene/282617</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Filippi C. M. TLR2 signaling improves immunoregulation to prevent type 1 diabetes / C. M. Filippi, K. Ehrhardt, E. A. Estes [et al.]. Eur J Immunol. 2011;41(5):1399-1409</mixed-citation><mixed-citation xml:lang="en">Filippi C. M. TLR2 signaling improves immunoregulation to prevent type 1 diabetes / C. M. Filippi, K. Ehrhardt, E. A. Estes [et al.]. Eur J Immunol. 2011;41(5):1399-1409</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gharbia OM. Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients / O.M. Gharbia, S.A. R Bassiouni, M.E.S Zaki [et al.]. Egyptian Rheumatology and Rehabilitation. 2021;48. ID 49</mixed-citation><mixed-citation xml:lang="en">Gharbia OM. Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients / O.M. Gharbia, S.A. R Bassiouni, M.E.S Zaki [et al.]. Egyptian Rheumatology and Rehabilitation. 2021;48. ID 49</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y. Analysis of the association of polymorphisms rs5743708 in TLR2 and rs4986790 in TLR4 with atopic dermatitis risk / Y. Zhang, H.-C. Wang, C. Feng, M. Yan Immunol Invest. 2019;48(2):169-180</mixed-citation><mixed-citation xml:lang="en">Zhang Y. Analysis of the association of polymorphisms rs5743708 in TLR2 and rs4986790 in TLR4 with atopic dermatitis risk / Y. Zhang, H.-C. Wang, C. Feng, M. Yan Immunol Invest. 2019;48(2):169-180</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gatselis NK. Programmed cell death-1 rs11568821 and interleukin28B rs12979860 polymorphisms in autoimmune hepatitis / N.K. Gatselis, K. Azariadis, A. Lyberopoulou, G.N. Dalekos. J Transl Autoimmun. 2021;4. ID 100126</mixed-citation><mixed-citation xml:lang="en">Gatselis NK. Programmed cell death-1 rs11568821 and interleukin28B rs12979860 polymorphisms in autoimmune hepatitis / N.K. Gatselis, K. Azariadis, A. Lyberopoulou, G.N. Dalekos. J Transl Autoimmun. 2021;4. ID 100126</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J.-Y. Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese / J.-Y. Chen, C.-M. Wang, T.-D. Chen [et al.]. Arthritis Res Ther. 2018;20(1). ID 193</mixed-citation><mixed-citation xml:lang="en">Chen J.-Y. Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese / J.-Y. Chen, C.-M. Wang, T.-D. Chen [et al.]. Arthritis Res Ther. 2018;20(1). ID 193</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
